CoChat

Translesion Polymerase η Is Upregulated by Cancer Therapeutics and Confers Anticancer Drug Resistance

Published version of a preprint

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

DNA repair processes are a key determinant of the sensitivity of cancer cells to DNA-damaging chemotherapeutics, which may induce certain repair genes as a mechanism to promote resistance. Here, we report the results of a screen for repair genes induced in cancer cells treated with DNA crosslinking agents, which identified the translesion polymerase η (PolH) as a p53-regulated target acting as one defense against interstrand crosslink (ICL)-inducing agents. PolH was induced by fotemustine, mafosfamide, and lomustine in breast cancer, glioma, and melanoma cells in vitro and in vivo, with similar inductions observed in normal cells such as lymphocytes and diploid fibroblasts. PolH contributions to the protection against ICL-inducing agents were evaluated by its siRNA-mediated attenuation in cells, which elevated sensitivity to these drugs in all tumor cell models. Conversely, PolH overexpression protected cancer cells against these drugs. PolH attenuation reduced repair of ICL lesions as measured by host cell reactivation assays and enhanced persistence of γH2AX foci. Moreover, we observed a strong accumulation of PolH in the nucleus of drug-treated cells along with direct binding to damaged DNA. Taken together, our findings implicated PolH in ICL repair as a mechanism of cancer drug resistance and normal tissue protection. Cancer Res; 74(19); 5585–96. ©2014 AACR.

Overview

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-14-0953

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 52 references

Cited by

See all 56

Metadata

Authors
Tomicic, M. T., Aasland, D., Naumann, S. C., Meise, R., Barckhausen, C., Kaina, B., & Christmann, M.
Affiliations
University Medical Center of the Johannes Gutenberg University Mainz (DE)
Venue
Cancer Research
Published
2014-09-30
Volume
74
Issue
19
Pages
5585-5596
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2018187217
Cited by
56
References
52
Citations by year
2026: 2 · 2025: 3 · 2024: 4 · 2023: 4 · 2022: 5 · 2021: 5 · 2020: 6 · 2019: 5 · 2018: 4 · 2017: 7 · 2016: 7 · 2015: 4
FWCI
2.46
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
Deutsche Forschungsgemeinschaft
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
  • Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
Keywords
DNA polymerase eta, interstrand crosslink repair, DNA repair, chemoresistance, p53 regulation, DNA cross-linking agents, fotemustine, mafosfamide, lomustine, host cell reactivation, γH2AX foci, normal tissue protection, breast cancer, glioma, melanoma
MeSH terms
Y-Family DNA Polymerases, Animals, Antineoplastic Agents, DNA-Directed DNA Polymerase, DNA Replication, Humans, Up-Regulation, Tumor Suppressor Protein p53, Mice, Inbred NOD, Drug Resistance, Neoplasm, Cell Line, Tumor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Translesion Polymerase η Is Upregulated by Cancer Therapeutics and Confers Anticancer Drug Resistance. https://app.cochat.ai/papers/10.1158/0008-5472.can-14-0953
The paper
Tomicic, M. T., Aasland, D., Naumann, S. C., Meise, R., Barckhausen, C., Kaina, B., & Christmann, M. (2014). Translesion Polymerase η Is Upregulated by Cancer Therapeutics and Confers Anticancer Drug Resistance. Cancer Research. https://doi.org/10.1158/0008-5472.can-14-0953

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.